"Regeneus Ltd (ASX: RGS), a clinical-stage regenerative medicine company, announced today that it was on track...."
"The company had disclosed that it anticipated completing the collaboration before the end of the first quarter in FY17 but unexpected delays in the sign off process has impacted completion"
Unexpected delays so they missed their own timeline but they are still on track... what the??
How can they still be "on track" when they ran out of track 2 weeks ago?
Not sure what to make of this ann tbh.
RGS Price at posting:
15.0¢ Sentiment: None Disclosure: Not Held
